Cox S R, Brown M A, Squires D J, Murrill E A, Lednicer D, Knuth D W
Pharmacokinetics/Pharmacodynamics Research, Upjohn Company, Kalamazoo, MI 49001.
Biopharm Drug Dispos. 1988 Nov-Dec;9(6):539-49. doi: 10.1002/bod.2510090604.
Twelve healthy male subjects participated in a two-way Latin square crossover study in which the treatments were a single 400 mg generic ibuprofen tablet (Tablet A) or a single 400 mg MOTRIN Tablet (Tablet B). Blood samples were drawn at various times through 12 h after dosing and plasma samples were assayed for ibuprofen enantiomers with a stereospecific capillary gas chromatographic procedure. Concentration-time data for both enantiomers were in agreement and indicated that drug was absorbed much more quickly from Tablet B than from the Tablet A; enantiomer Tmax values were less than 1.3 h from Tablet B but longer than 4 h from the Tablet A (p less than 0.001). Also, maximum enantiomer plasma concentrations from the Tablet B were about 50 per cent of the peak concentrations observed from Tablet A (p less than 0.001). The total extent of drug absorption appeared to be the same in both products. These data clearly indicate that the two tablets are not bioequivalent with respect to either ibuprofen enantiomer.
12名健康男性受试者参与了一项两因素拉丁方交叉研究,其中治疗药物为一片400毫克的普通布洛芬片剂(片剂A)或一片400毫克的布洛芬片(片剂B)。给药后12小时内不同时间采集血样,采用立体特异性毛细管气相色谱法测定血浆样品中的布洛芬对映体。两种对映体的浓度-时间数据一致,表明药物从片剂B的吸收比从片剂A快得多;片剂B的对映体达峰时间(Tmax)值小于1.3小时,而片剂A的则超过4小时(p<0.001)。此外,片剂B的对映体血浆最大浓度约为片剂A观察到的峰值浓度的50%(p<0.001)。两种产品的药物吸收总程度似乎相同。这些数据清楚地表明,就布洛芬对映体而言,这两种片剂并非生物等效。